# Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

> **NCT00184951** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (—)

## Conditions studied

- HIV Infections
- Hyperlipidemia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00184951
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 30 (—)
- **Last updated:** 2020-11-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184951, "Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00184951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*